Precision BioSciences Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 10, 2021, details the results of the annual meeting of stockholders held by Precision BioSciences, Inc. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol DTIL. The report covers the voting outcomes for director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events rather than financial performance.
Material Changes and Voting Results
A total of 40,424,562 shares were present at the meeting, representing approximately 70.74% of the outstanding common stock as of the March 15, 2021 record date. The following proposals were approved:
- Item 1 (Election of Directors): Two Class II directors were elected to serve until the 2024 annual meeting.
- Stanley R. Frankel, M.D.: Received 29,072,575 votes FOR, 100,471 votes WITHHELD, and 11,251,516 Broker Non-Votes.
- Derek Jantz, Ph.D.: Received 21,372,075 votes FOR, 7,800,971 votes WITHHELD, and 11,251,516 Broker Non-Votes.
- Item 2 (Ratification of Auditor): The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2021, was ratified.
- Votes FOR: 40,212,612
- Votes AGAINST: 175,384
- Votes ABSTAINED: 36,566
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of stockholder vote results.
Key Facts for Investor Verification
- Verify the tenure of the newly elected Class II directors (Stanley R. Frankel and Derek Jantz) through the 2024 annual meeting.
- Confirm the engagement of Deloitte & Touche LLP for the fiscal year ending December 31, 2021.
- Note the significant number of broker non-votes (11,251,516) regarding the director elections, which may indicate shares held in street name where brokers lacked discretionary voting power.
- Review the Definitive Proxy Statement filed on April 12, 2021, for detailed biographies of the directors and further context on the proposals.